Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Current Opinion in Molecular Therapeutics|March 16, 2001
Viral vectors for gene transfer into antigen presenting cellsS J Monahan, M L SalgallerExpert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: Clinical trials of immunotherapeutics and immunologic monitoring. April 1-5, 2000, San Francisco, CA, USAM L SalgallerIdrugs : the Investigational Drugs Journal|August 5, 2005
AACR - 91st meeting. Dendritic cell vaccine strategiesM L SalgallerExpert Opinion on Investigational Drugs|November 4, 2000
Prostate cancer immunotherapy at the dawn of the new millenniumM L SalgallerExpert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: dendritic cells: strategies and vaccines. April 1-5, 2000, San Francisco, CA, USAM L SalgallerCurrent Opinion in Molecular Therapeutics|March 16, 2001
Immune monitoring of cancer patients undergoing experimental immunotherapyG Shankar, M L SalgallerJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cellsP A Lodge, R A Childs, S J Monahan, et al.Expert Opinion on Investigational Drugs|November 4, 2000
Immunologic approaches to antigen discovery for cancer vaccinesL A Jones, M L SalgallerJournal of Biomedical Materials Research|January 1, 1985
Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbitsM L Salgaller, P K BajpaiExpert Opinion on Investigational Drugs|July 5, 2005
Therapeutic potential of dendritic-based vaccinesL A Jones, M L SalgallerPageof 5